GEMCITABINE HYDROCHLORIDE

GEMCITABINE HYDROCHLORIDE was reported 54063 times

GEMCITABINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DESMOPLASTIC SMALL ROUND CELL TUMOUR 38 0.4368
1 PSEUDOCELLULITIS 74 0.3458
2 REFRACTORY CANCER 56 0.2617
3 PLATELET TOXICITY 23 0.2500
4 PSEUDOCIRRHOSIS 76 0.2289
5 BILIARY TRACT INFECTION 130 0.2090
6 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 393 0.1781
7 RECALL PHENOMENON 141 0.1687
8 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 157 0.1658
9 DUCTAL ADENOCARCINOMA OF PANCREAS 43 0.1552
10 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 31 0.1348
11 CHOLANGITIS INFECTIVE 35 0.1316
12 PIK3CA-ACTIVATED MUTATION 43 0.1295
13 BILIARY SEPSIS 59 0.1274
14 PANCREATIC CARCINOMA RECURRENT 28 0.1162
15 PANCREATIC ABSCESS 23 0.1139
16 PANCREATIC CARCINOMA METASTATIC 299 0.1050
17 HAEMOLYTIC URAEMIC SYNDROME 239 0.1030
18 THROMBOTIC MICROANGIOPATHY 963 0.0987
19 THROMBOPHLEBITIS MIGRANS 33 0.0971
20 CHOLANGITIS 588 0.0947
21 TOXIC ERYTHEMA OF CHEMOTHERAPY 23 0.0888
22 CAPILLARY LEAK SYNDROME 174 0.0841
23 CONGENITAL APLASIA 25 0.0804
24 METASTASES TO BONE MARROW 40 0.0800
25 METASTASES TO CHEST WALL 27 0.0778
26 CARBOHYDRATE ANTIGEN 19-9 INCREASED 41 0.0775
27 ADENOCARCINOMA PANCREAS 99 0.0770
28 FOLLICULAR LYMPHOMA 65 0.0739
29 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 57 0.0701
30 DUODENAL OBSTRUCTION 21 0.0700
31 HYPERCALCAEMIA OF MALIGNANCY 19 0.0699
32 METASTASES TO SPLEEN 28 0.0678
33 METASTASES TO PERITONEUM 170 0.0672
34 HAEMATOTOXICITY 619 0.0651
35 POST THROMBOTIC SYNDROME 29 0.0644
36 EGFR GENE MUTATION 24 0.0642
37 DUODENAL STENOSIS 30 0.0617
38 TUMOUR ASSOCIATED FEVER 25 0.0611
39 CHOLANGIOCARCINOMA 87 0.0584
40 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 46 0.0584
41 ENTEROCOLITIS INFECTIOUS 52 0.0563
42 NEUTROPENIC SEPSIS 402 0.0562
43 METASTASES TO SKIN 58 0.0561
44 BILE DUCT STENOSIS 67 0.0559
45 AORTIC THROMBOSIS 63 0.0545
46 DIFFUSE LARGE B-CELL LYMPHOMA 420 0.0545
47 HEPATITIS B CORE ANTIBODY POSITIVE 20 0.0531
48 CHOLANGITIS ACUTE 40 0.0530
49 LIVER ABSCESS 163 0.0502
50 BONE MARROW INFILTRATION 19 0.0491
51 MYELOSUPPRESSION 1742 0.0483
52 HAEMOBILIA 20 0.0482
53 OVARIAN CANCER METASTATIC 40 0.0471
54 B-CELL LYMPHOMA RECURRENT 25 0.0460
55 GASTROINTESTINAL TOXICITY 217 0.0451
56 MALIGNANT ASCITES 34 0.0443
57 NEUTROPENIC INFECTION 41 0.0428
58 DISEASE PROGRESSION 4940 0.0417
59 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 31 0.0396
60 STENT OCCLUSION 21 0.0395
61 DRY GANGRENE 25 0.0394
62 BILIARY OBSTRUCTION 51 0.0393
63 OVARIAN CANCER RECURRENT 62 0.0386
64 EXTREMITY NECROSIS 66 0.0378
65 MUSCLE NECROSIS 33 0.0363
66 METASTASES TO PLEURA 38 0.0362
67 BLADDER CANCER RECURRENT 36 0.0361
68 VENA CAVA THROMBOSIS 60 0.0361
69 BONE MARROW TOXICITY 42 0.0354
70 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 21 0.0354
71 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 63 0.0354
72 ACQUIRED GENE MUTATION 46 0.0351
73 METASTASES TO LUNG 404 0.0349
74 TRIPLE NEGATIVE BREAST CANCER 23 0.0342
75 HYPERTRANSAMINASAEMIA 237 0.0340
76 THROMBOCYTOPENIA 3805 0.0340
77 METASTASES TO LIVER 593 0.0337
78 METASTASES TO LYMPH NODES 226 0.0335
79 THERAPY PARTIAL RESPONDER 519 0.0332
80 BILE DUCT OBSTRUCTION 63 0.0332
81 PERITONEAL DISORDER 21 0.0324
82 NEOPLASM PROGRESSION 1122 0.0322
83 OBSTRUCTION GASTRIC 41 0.0319
84 CYTOPENIA 390 0.0318
85 METASTASES TO PELVIS 20 0.0316
86 BICYTOPENIA 62 0.0316
87 TRANSITIONAL CELL CARCINOMA 41 0.0316
88 IMMUNE-MEDIATED HEPATITIS 64 0.0313
89 PERIPHERAL SENSORY NEUROPATHY 183 0.0313
90 NEOPLASM RECURRENCE 106 0.0312
91 THROMBOTIC THROMBOCYTOPENIC PURPURA 110 0.0312
92 KLEBSIELLA TEST POSITIVE 20 0.0307
93 LYMPHANGIOSIS CARCINOMATOSA 31 0.0298
94 THROMBOCYTOSIS 109 0.0297
95 CYTOKINE RELEASE SYNDROME 594 0.0296
96 TUMOUR NECROSIS 31 0.0293
97 METASTASES TO ADRENALS 27 0.0293
98 MYCOSIS FUNGOIDES 24 0.0292
99 MALIGNANT NEOPLASM PROGRESSION 2987 0.0291
100 ANISOCYTOSIS 19 0.0289
101 PULMONARY TOXICITY 202 0.0285
102 MYOSITIS 256 0.0285
103 PERIPHERAL ISCHAEMIA 116 0.0284
104 IMMUNE-MEDIATED HYPOTHYROIDISM 32 0.0284
105 RETINAL TOXICITY 29 0.0282
106 FEBRILE NEUTROPENIA 1861 0.0280
107 OTOTOXICITY 51 0.0276
108 PANCREATIC MASS 29 0.0271
109 TUMOUR LYSIS SYNDROME 234 0.0266
110 SYSTEMIC INFECTION 44 0.0265
111 ALVEOLITIS 37 0.0262
112 LYMPHANGITIS 21 0.0261
113 HYPERPYREXIA 109 0.0257
114 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 32 0.0257
115 HYPOALBUMINAEMIA 199 0.0256
116 FEBRILE INFECTION 30 0.0255
117 KLEBSIELLA SEPSIS 28 0.0248
118 NEUTROPENIA 3364 0.0247
119 IMMUNE-MEDIATED HEPATIC DISORDER 48 0.0246
120 LYMPHADENOPATHY MEDIASTINAL 47 0.0245
121 BILIARY DILATATION 36 0.0245
122 PANCYTOPENIA 1369 0.0245
123 GRANULOCYTE COUNT DECREASED 45 0.0242
124 PERFORMANCE STATUS DECREASED 112 0.0240
125 LEUKOPENIA 1184 0.0236
126 EMBOLISM 196 0.0236
127 BONE MARROW FAILURE 478 0.0235
128 MUCOSAL INFLAMMATION 613 0.0234
129 SECOND PRIMARY MALIGNANCY 194 0.0233
130 JAUNDICE CHOLESTATIC 82 0.0232
131 SKIN TOXICITY 131 0.0232
132 IMMUNE-MEDIATED MYOCARDITIS 37 0.0229
133 METASTASES TO MENINGES 52 0.0228
134 IMMUNE-MEDIATED DERMATITIS 23 0.0228
135 DUODENAL PERFORATION 22 0.0224
136 POSTICTAL STATE 23 0.0221
137 PERIPHERAL MOTOR NEUROPATHY 31 0.0221
138 KLEBSIELLA BACTERAEMIA 21 0.0221
139 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 130 0.0219
140 ACUTE MYELOID LEUKAEMIA 340 0.0218
141 NEUROTOXICITY 382 0.0218
142 NEUTROPHIL COUNT DECREASED 886 0.0217
143 EMBOLISM ARTERIAL 26 0.0216
144 BLOOD LACTATE DEHYDROGENASE INCREASED 343 0.0216
145 MYELODYSPLASTIC SYNDROME 311 0.0215
146 URINARY TRACT INFECTION ENTEROCOCCAL 20 0.0214
147 SYSTEMIC CANDIDA 53 0.0211
148 PNEUMONITIS 571 0.0209
149 BREAST CANCER METASTATIC 225 0.0209
150 BACTERAEMIA 248 0.0209
151 ESCHERICHIA BACTERAEMIA 49 0.0208
152 ASCITES 612 0.0208
153 SMALL INTESTINAL PERFORATION 39 0.0208
154 CATHETER RELATED INFECTION 21 0.0207
155 METASTASES TO CENTRAL NERVOUS SYSTEM 261 0.0202
156 SUBCLAVIAN VEIN THROMBOSIS 23 0.0202
157 TUMOUR PSEUDOPROGRESSION 22 0.0201
158 SPLENIC INFARCTION 35 0.0200
159 MYELITIS TRANSVERSE 28 0.0199
160 METASTASES TO BONE 323 0.0197
161 PELVIC VENOUS THROMBOSIS 28 0.0195
162 PORTAL VEIN THROMBOSIS 63 0.0195
163 BILE DUCT CANCER 23 0.0193
164 HYPERSENSITIVITY PNEUMONITIS 22 0.0193
165 METASTASIS 137 0.0192
166 HYPERAMMONAEMIC ENCEPHALOPATHY 33 0.0190
167 POLYNEUROPATHY 227 0.0189
168 HEPATIC INFECTION 24 0.0188
169 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 179 0.0187
170 ADENOCARCINOMA 42 0.0187
171 NON-SMALL CELL LUNG CANCER 89 0.0186
172 CYTOMEGALOVIRUS CHORIORETINITIS 36 0.0184
173 NEUTROPHIL COUNT ABNORMAL 52 0.0184
174 RENAL TUBULAR INJURY 22 0.0181
175 ENTEROCOCCAL BACTERAEMIA 19 0.0179
176 PERIPHERAL ARTERY THROMBOSIS 25 0.0178
177 MALIGNANT PLEURAL EFFUSION 30 0.0178
178 OSTEOSCLEROSIS 28 0.0178
179 AZOTAEMIA 71 0.0178
180 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 47 0.0177
181 NORMOCHROMIC NORMOCYTIC ANAEMIA 53 0.0176
182 OSTEOLYSIS 36 0.0176
183 ESCHERICHIA SEPSIS 51 0.0176
184 IMMUNE-MEDIATED ADVERSE REACTION 27 0.0176
185 NEPHROPATHY TOXIC 194 0.0173
186 HYPERPHOSPHATAEMIA 37 0.0172
187 PNEUMOCYSTIS JIROVECII PNEUMONIA 172 0.0171
188 DERMATITIS ACNEIFORM 104 0.0171
189 PERIPHERAL ARTERY OCCLUSION 24 0.0171
190 METASTASES TO SPINE 57 0.0169
191 CARDIOTOXICITY 151 0.0169
192 URETERIC OBSTRUCTION 23 0.0168
193 PORTAL HYPERTENSION 52 0.0168
194 ENTEROCOLITIS 97 0.0168
195 HYPERBILIRUBINAEMIA 174 0.0168
196 HEPATIC CYTOLYSIS 214 0.0168
197 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 389 0.0167
198 GENE MUTATION 33 0.0167
199 HEPATIC MASS 32 0.0166
200 ANAEMIA 3158 0.0165
201 INVASIVE DUCTAL BREAST CARCINOMA 45 0.0165
202 BREAST CANCER RECURRENT 52 0.0164
203 CYSTOID MACULAR OEDEMA 31 0.0164
204 ABDOMINAL INFECTION 42 0.0164
205 CEREBRAL ISCHAEMIA 84 0.0163
206 URINARY TRACT OBSTRUCTION 38 0.0160
207 BILIARY TRACT DISORDER 22 0.0159
208 EMBOLISM VENOUS 48 0.0158
209 FEBRILE BONE MARROW APLASIA 67 0.0157
210 METASTATIC NEOPLASM 68 0.0157
211 FAILURE TO THRIVE 81 0.0156
212 SMALL INTESTINAL HAEMORRHAGE 31 0.0154
213 LYMPHOMA 235 0.0152
214 TUMOUR PAIN 20 0.0152
215 ENTERITIS 96 0.0150
216 DYSAESTHESIA 45 0.0147
217 MIXED LIVER INJURY 44 0.0146
218 RENAL INFARCT 21 0.0145
219 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 19 0.0144
220 HEPATIC LESION 62 0.0143
221 VENOUS THROMBOSIS 56 0.0143
222 THROMBOPHLEBITIS 50 0.0142
223 CULTURE URINE POSITIVE 20 0.0142
224 NEUROPATHY PERIPHERAL 1352 0.0142
225 GASTROINTESTINAL PERFORATION 59 0.0142
226 CELL DEATH 28 0.0141
227 UROSEPSIS 130 0.0141
228 SUBILEUS 29 0.0139
229 PLEURAL EFFUSION 839 0.0138
230 RECURRENT CANCER 56 0.0137
231 COMPUTERISED TOMOGRAM ABNORMAL 31 0.0137
232 SOFT TISSUE INFECTION 25 0.0136
233 HEPATORENAL SYNDROME 23 0.0136
234 LEFT VENTRICULAR DYSFUNCTION 91 0.0136
235 NEUTROPENIC COLITIS 28 0.0135
236 ORGANISING PNEUMONIA 67 0.0135
237 DRUG RESISTANCE 347 0.0135
238 ISCHAEMIA 62 0.0135
239 LARYNGOSPASM 36 0.0134
240 LUNG ADENOCARCINOMA 40 0.0133
241 HYDRONEPHROSIS 99 0.0132
242 HYPOMAGNESAEMIA 184 0.0132
243 HYPOPROTEINAEMIA 25 0.0132
244 IMMUNE-MEDIATED LUNG DISEASE 24 0.0132
245 PSEUDOMONAL SEPSIS 23 0.0131
246 HEPATOTOXICITY 292 0.0131
247 HYPOPHOSPHATAEMIA 94 0.0127
248 URINARY TRACT INFECTION BACTERIAL 32 0.0126
249 TROPONIN I INCREASED 21 0.0126
250 KLEBSIELLA INFECTION 63 0.0124
251 LYMPHOEDEMA 86 0.0124
252 SEPTIC SHOCK 541 0.0124
253 SMALL INTESTINAL OBSTRUCTION 152 0.0123
254 TRANSAMINASES INCREASED 274 0.0123
255 IMMUNE-MEDIATED ENTEROCOLITIS 45 0.0122
256 ATELECTASIS 117 0.0121
257 INTERSTITIAL LUNG DISEASE 584 0.0120
258 MENINGITIS CRYPTOCOCCAL 21 0.0120
259 SUSPECTED OFF LABEL USE 54 0.0119
260 PLATELET COUNT DECREASED 1266 0.0119
261 CARCINOEMBRYONIC ANTIGEN INCREASED 23 0.0119
262 SKIN NECROSIS 61 0.0117
263 STAPHYLOCOCCAL BACTERAEMIA 51 0.0117
264 LIVEDO RETICULARIS 24 0.0115
265 LYMPHOPENIA 162 0.0114
266 GRAFT VERSUS HOST DISEASE 82 0.0114
267 LUNG OPACITY 30 0.0114
268 GASTRIC PERFORATION 31 0.0114
269 CARDIAC TAMPONADE 54 0.0114
270 SEPSIS 1264 0.0113
271 GASTROINTESTINAL ULCER 25 0.0113
272 PULMONARY ALVEOLAR HAEMORRHAGE 63 0.0112
273 ARTERIOSPASM CORONARY 45 0.0112
274 GASTROINTESTINAL OBSTRUCTION 27 0.0112
275 ORAL INTAKE REDUCED 27 0.0112
276 HAEMOLYTIC ANAEMIA 100 0.0112
277 VENOUS THROMBOSIS LIMB 23 0.0111
278 PROTEINURIA 210 0.0110
279 ARTERIAL THROMBOSIS 21 0.0109
280 TUMOUR HAEMORRHAGE 31 0.0109
281 RED CELL DISTRIBUTION WIDTH INCREASED 45 0.0108
282 PERICARDIAL EFFUSION 249 0.0108
283 PANNICULITIS 26 0.0107
284 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 41 0.0107
285 IMMUNE THROMBOCYTOPENIA 49 0.0107
286 QUADRIPLEGIA 22 0.0107
287 MULTIPLE-DRUG RESISTANCE 33 0.0106
288 ACUTE RESPIRATORY DISTRESS SYNDROME 188 0.0106
289 OESOPHAGEAL VARICES HAEMORRHAGE 23 0.0106
290 DISSEMINATED INTRAVASCULAR COAGULATION 148 0.0105
291 HEPATOCELLULAR INJURY 149 0.0105
292 PULMONARY EMBOLISM 996 0.0105
293 BLOOD BILIRUBIN INCREASED 283 0.0105
294 LUNG INFILTRATION 92 0.0104
295 BLOOD CULTURE POSITIVE 31 0.0103
296 ACUTE PULMONARY OEDEMA 58 0.0103
297 CACHEXIA 53 0.0103
298 TROPONIN INCREASED 78 0.0102
299 LYMPHOCYTOSIS 22 0.0102
300 MACULAR OEDEMA 57 0.0102
301 RENAL COLIC 23 0.0102
302 ERYSIPELAS 51 0.0101
303 VENOOCCLUSIVE LIVER DISEASE 50 0.0101
304 ILEUS PARALYTIC 45 0.0101
305 ABDOMINAL MASS 27 0.0101
306 DEEP VEIN THROMBOSIS 651 0.0100
307 TUMOUR MARKER INCREASED 48 0.0100
308 BLOOD ALKALINE PHOSPHATASE INCREASED 248 0.0100
309 BONE LESION 36 0.0100
310 CHOLESTASIS 190 0.0099
311 NECROSIS 55 0.0099
312 CANCER PAIN 25 0.0098
313 HYPERCALCAEMIA 120 0.0097
314 BLOOD ALBUMIN DECREASED 77 0.0097
315 CYSTITIS HAEMORRHAGIC 39 0.0097
316 DISEASE RECURRENCE 454 0.0095
317 PNEUMOTHORAX 151 0.0095
318 NEPHROTIC SYNDROME 65 0.0095
319 AGRANULOCYTOSIS 176 0.0095
320 MULTIPLE ORGAN DYSFUNCTION SYNDROME 266 0.0094
321 LUNG CANCER METASTATIC 27 0.0094
322 GENERAL PHYSICAL HEALTH DETERIORATION 1082 0.0093
323 PARONYCHIA 41 0.0093
324 ENTEROCOCCAL INFECTION 45 0.0093
325 LEFT VENTRICULAR FAILURE 32 0.0093
326 LUNG CONSOLIDATION 26 0.0093
327 GENERALISED OEDEMA 115 0.0093
328 HEPATIC FAILURE 280 0.0093
329 PANCREATIC CARCINOMA 268 0.0093
330 BONE MARROW DISORDER 28 0.0093
331 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 47 0.0092
332 COLITIS 349 0.0092
333 ACUTE LYMPHOCYTIC LEUKAEMIA 26 0.0092
334 ESCHERICHIA URINARY TRACT INFECTION 39 0.0092
335 ILEUS 114 0.0092
336 CARDIAC FAILURE ACUTE 61 0.0091
337 HYPOKALAEMIA 422 0.0091
338 HEPATITIS B 55 0.0091
339 DUODENITIS 28 0.0091
340 AUTOIMMUNE HAEMOLYTIC ANAEMIA 31 0.0090
341 HICCUPS 74 0.0090
342 PHLEBITIS 46 0.0090
343 AMYLASE INCREASED 33 0.0089
344 LYMPHOCYTE COUNT DECREASED 158 0.0089
345 DUODENAL ULCER 63 0.0089
346 STAPHYLOCOCCAL SEPSIS 44 0.0089
347 HYPERVOLAEMIA 44 0.0089
348 BLOOD DISORDER 71 0.0089
349 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 66 0.0088
350 STRESS CARDIOMYOPATHY 51 0.0088
351 ATYPICAL PNEUMONIA 26 0.0087
352 JAUNDICE 232 0.0086
353 PNEUMONIA BACTERIAL 79 0.0086
354 RETINOPATHY 32 0.0086
355 BILIRUBIN CONJUGATED INCREASED 20 0.0086
356 INTESTINAL PERFORATION 96 0.0085
357 HEPATIC FUNCTION ABNORMAL 319 0.0085
358 CHOLESTATIC LIVER INJURY 19 0.0085
359 BLOOD CHLORIDE DECREASED 22 0.0085
360 ESCHERICHIA INFECTION 70 0.0085
361 HYPONATRAEMIA 479 0.0085
362 HEPATITIS CHOLESTATIC 51 0.0085
363 LEUKOCYTOSIS 153 0.0084
364 METABOLIC DISORDER 49 0.0084
365 RASH MACULO-PAPULAR 187 0.0084
366 CARDIOMYOPATHY 124 0.0084
367 LARGE INTESTINE PERFORATION 58 0.0083
368 ASPARTATE AMINOTRANSFERASE INCREASED 440 0.0083
369 HAEMOGLOBIN ABNORMAL 53 0.0082
370 WHITE BLOOD CELL DISORDER 22 0.0082
371 CLOSTRIDIUM DIFFICILE COLITIS 86 0.0081
372 HYPOCALCAEMIA 153 0.0081
373 ALANINE AMINOTRANSFERASE INCREASED 496 0.0081
374 CHOLECYSTITIS 96 0.0081
375 UPPER GASTROINTESTINAL HAEMORRHAGE 135 0.0080
376 TACHYARRHYTHMIA 20 0.0080
377 BACTERIAL SEPSIS 26 0.0080
378 B-CELL LYMPHOMA 27 0.0079
379 CYTOMEGALOVIRUS INFECTION REACTIVATION 35 0.0079
380 PLEURISY 47 0.0079
381 PNEUMONIA FUNGAL 31 0.0079
382 PNEUMONIA VIRAL 25 0.0078
383 ELECTROLYTE IMBALANCE 91 0.0078
384 WHITE BLOOD CELL COUNT DECREASED 844 0.0078
385 VENTRICULAR HYPOKINESIA 25 0.0078
386 GLOMERULONEPHRITIS 19 0.0078
387 SCLERODERMA 28 0.0077
388 PROTEIN TOTAL DECREASED 29 0.0077
389 DUODENAL ULCER HAEMORRHAGE 22 0.0077
390 THERAPY NON-RESPONDER 345 0.0077
391 HYPOXIA 269 0.0076
392 CARBOHYDRATE ANTIGEN 125 INCREASED 26 0.0076
393 COVID-19 PNEUMONIA 90 0.0076
394 IMMUNE-MEDIATED MYOSITIS 21 0.0076
395 PYREXIA 2636 0.0076
396 HYPERAMMONAEMIA 38 0.0076
397 OVARIAN CANCER 70 0.0076
398 HEPATITIS B REACTIVATION 24 0.0076
399 CARDIAC DYSFUNCTION 28 0.0075
400 RESPIRATORY FAILURE 546 0.0075
401 BRONCHOPULMONARY ASPERGILLOSIS 58 0.0075
402 DERMATITIS EXFOLIATIVE GENERALISED 26 0.0075
403 NEUTROPHIL COUNT INCREASED 76 0.0074
404 ACUTE CORONARY SYNDROME 61 0.0074
405 LYMPHADENOPATHY 260 0.0073
406 SINUS TACHYCARDIA 104 0.0073
407 C-REACTIVE PROTEIN INCREASED 266 0.0073
408 VARICES OESOPHAGEAL 22 0.0073
409 GAMMA-GLUTAMYLTRANSFERASE INCREASED 161 0.0073
410 THROMBOPHLEBITIS SUPERFICIAL 22 0.0073
411 HAEMOLYSIS 56 0.0072
412 GUILLAIN-BARRE SYNDROME 35 0.0072
413 HAEMOGLOBIN DECREASED 742 0.0072
414 HAEMOPTYSIS 199 0.0071
415 ACUTE KIDNEY INJURY 1087 0.0071
416 INFLAMMATORY MARKER INCREASED 35 0.0071
417 PNEUMATOSIS INTESTINALIS 20 0.0070
418 THYROIDITIS 21 0.0070
419 ATRIOVENTRICULAR BLOCK SECOND DEGREE 21 0.0069
420 LIPASE INCREASED 53 0.0069
421 ATRIAL FLUTTER 55 0.0069
422 MONOCYTE COUNT INCREASED 25 0.0069
423 PSEUDOMONAS INFECTION 59 0.0069
424 HYPOVOLAEMIA 40 0.0068
425 LUNG INFECTION 106 0.0068
426 DEVICE RELATED INFECTION 105 0.0068
427 HYPERURICAEMIA 28 0.0068
428 CLOSTRIDIAL INFECTION 23 0.0068
429 ACUTE RESPIRATORY FAILURE 130 0.0068
430 HEPATIC NEOPLASM 22 0.0067
431 RENAL TUBULAR NECROSIS 66 0.0067
432 EPSTEIN-BARR VIRUS INFECTION 42 0.0067
433 HAEMATOCRIT DECREASED 133 0.0067
434 EJECTION FRACTION DECREASED 104 0.0067
435 OESOPHAGITIS 73 0.0067
436 MYOCARDITIS 76 0.0066
437 HEPATITIS ACUTE 43 0.0066
438 SUPRAVENTRICULAR TACHYCARDIA 63 0.0066
439 TYPE I HYPERSENSITIVITY 23 0.0065
440 LOCALISED OEDEMA 30 0.0065
441 PLATELET COUNT ABNORMAL 39 0.0064
442 HEPATITIS FULMINANT 19 0.0064
443 SKIN MASS 42 0.0063
444 NEPHRITIS 21 0.0063
445 ORTHOPNOEA 20 0.0063
446 HAEMATURIA 215 0.0063
447 BACTERIAL INFECTION 117 0.0063
448 DEHYDRATION 830 0.0062
449 PLATELET COUNT INCREASED 81 0.0062
450 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 48 0.0062
451 SPINAL CORD COMPRESSION 24 0.0062
452 CHRONIC LYMPHOCYTIC LEUKAEMIA 29 0.0061
453 WHITE BLOOD CELL COUNT ABNORMAL 39 0.0061
454 PULMONARY MASS 91 0.0061
455 OEDEMA PERIPHERAL 744 0.0061
456 HYPOPHAGIA 156 0.0061
457 ADRENAL INSUFFICIENCY 74 0.0061
458 CHRONIC GRAFT VERSUS HOST DISEASE 22 0.0061
459 NEOPLASM 70 0.0061
460 HYPOGAMMAGLOBULINAEMIA 40 0.0061
461 FLANK PAIN 57 0.0061
462 BLOOD CREATININE INCREASED 396 0.0061
463 HEPATITIS 155 0.0061
464 PYELONEPHRITIS 52 0.0060
465 CEREBRAL INFARCTION 146 0.0060
466 MYOCARDIAL ISCHAEMIA 68 0.0060
467 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 61 0.0059
468 CARDIOPULMONARY FAILURE 23 0.0059
469 DEVICE OCCLUSION 83 0.0059
470 HEPATIC CYST 20 0.0059
471 HYPOTHYROIDISM 187 0.0058
472 EXTRAVASATION 24 0.0058
473 GRANULOCYTOPENIA 33 0.0058
474 PURPURA 51 0.0058
475 CONGESTIVE CARDIOMYOPATHY 24 0.0058
476 HYPERTHYROIDISM 83 0.0057
477 MALNUTRITION 64 0.0057
478 RENAL FAILURE ACUTE 239 0.0056
479 LUNG NEOPLASM 24 0.0056
480 PULMONARY TUBERCULOSIS 24 0.0056
481 RENAL IMPAIRMENT 471 0.0056
482 STOMATITIS 340 0.0056
483 RENAL FAILURE CHRONIC 43 0.0056
484 CELLULITIS 281 0.0056
485 HYPERGLYCAEMIA 203 0.0056
486 SKIN INFECTION 61 0.0054
487 CARDIAC FAILURE 435 0.0054
488 OSTEONECROSIS OF JAW 134 0.0054
489 ORAL CANDIDIASIS 71 0.0054
490 SUDDEN DEATH 57 0.0054
491 BLOOD URIC ACID INCREASED 31 0.0054
492 OEDEMA 291 0.0054
493 HEPATIC ENCEPHALOPATHY 50 0.0054
494 COLITIS ISCHAEMIC 36 0.0053
495 BLOOD MAGNESIUM DECREASED 46 0.0053
496 ABDOMINAL PAIN 1238 0.0053
497 PATHOLOGICAL FRACTURE 27 0.0053
498 TUBULOINTERSTITIAL NEPHRITIS 99 0.0053
499 ISCHAEMIC STROKE 94 0.0053
500 DIVERTICULUM INTESTINAL 23 0.0053
501 ACUTE MYOCARDIAL INFARCTION 155 0.0053
502 ATRIOVENTRICULAR BLOCK COMPLETE 35 0.0052
503 HYPERKALAEMIA 183 0.0052
504 CANDIDA INFECTION 88 0.0052
505 PROTHROMBIN TIME PROLONGED 31 0.0052
506 ANGIOPATHY 29 0.0052
507 DERMATITIS 108 0.0051
508 HEPATIC PAIN 22 0.0051
509 PRESYNCOPE 125 0.0051
510 DRUG-INDUCED LIVER INJURY 161 0.0051
511 SPLENOMEGALY 60 0.0051
512 CHOLECYSTITIS ACUTE 29 0.0051
513 HYPERTHERMIA 39 0.0051
514 VASCULITIS 59 0.0051
515 DRUG INTOLERANCE 489 0.0051
516 BODY TEMPERATURE INCREASED 103 0.0050
517 ABDOMINAL ABSCESS 22 0.0050
518 DECREASED APPETITE 1148 0.0049
519 BLOOD LACTIC ACID INCREASED 26 0.0049
520 INFECTION 714 0.0049
521 INTESTINAL ISCHAEMIA 27 0.0049
522 HAEMATEMESIS 124 0.0049
523 ENCEPHALOPATHY 120 0.0049
524 OFF LABEL USE 4270 0.0049
525 TREATMENT FAILURE 403 0.0049
526 DYSPNOEA EXERTIONAL 181 0.0048
527 HYPERTENSIVE CRISIS 53 0.0048
528 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 24 0.0047
529 ANOREXIA 61 0.0047
530 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 39 0.0047
531 PANCREATITIS ACUTE 106 0.0047
532 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 335 0.0047
533 EPISTAXIS 352 0.0047
534 PETECHIAE 49 0.0047
535 ODYNOPHAGIA 28 0.0047
536 LUNG DISORDER 229 0.0047
537 OLIGURIA 29 0.0047
538 TOXIC SKIN ERUPTION 47 0.0047
539 BLOOD UREA INCREASED 78 0.0047
540 PAPILLOEDEMA 21 0.0046
541 PNEUMONIA 1499 0.0046
542 PERONEAL NERVE PALSY 26 0.0046
543 VOMITING 2149 0.0046
544 BLOOD SODIUM DECREASED 86 0.0046
545 TOXICITY TO VARIOUS AGENTS 759 0.0045
546 LIVER INJURY 110 0.0045
547 GASTROINTESTINAL HAEMORRHAGE 374 0.0045
548 CYTOMEGALOVIRUS INFECTION 74 0.0044
549 WHITE BLOOD CELL COUNT INCREASED 170 0.0044
550 MENTAL STATUS CHANGES 123 0.0044
551 ASPERGILLUS INFECTION 29 0.0044
552 PULSE ABSENT 21 0.0044
553 ACUTE HEPATIC FAILURE 60 0.0044
554 CLOSTRIDIUM DIFFICILE INFECTION 95 0.0043
555 RETINAL HAEMORRHAGE 31 0.0043
556 SENSORY LOSS 35 0.0043
557 DRUG ERUPTION 77 0.0043
558 RED BLOOD CELL COUNT DECREASED 124 0.0043
559 PRODUCT USE IN UNAPPROVED INDICATION 1074 0.0043
560 INTESTINAL OBSTRUCTION 163 0.0043
561 MELAENA 95 0.0043
562 DRUG TOXICITY 58 0.0043
563 ABDOMINAL TENDERNESS 21 0.0042
564 NEUTROPHILIA 24 0.0042
565 PULMONARY OEDEMA 188 0.0042
566 DERMATITIS EXFOLIATIVE 21 0.0042
567 ACIDOSIS 32 0.0042
568 HYPOVOLAEMIC SHOCK 20 0.0042
569 PULMONARY FIBROSIS 80 0.0042
570 ASTHENIA 1564 0.0042
571 GASTRIC ULCER 79 0.0042
572 CARDIOMEGALY 51 0.0041
573 RENAL FAILURE 547 0.0041
574 ANAPHYLACTIC SHOCK 106 0.0041
575 SHOCK 94 0.0041
576 CYANOSIS 64 0.0041
577 CHILLS 477 0.0041
578 PANCREATIC DISORDER 20 0.0041
579 HEPATITIS C 49 0.0041
580 LIVER FUNCTION TEST ABNORMAL 117 0.0040
581 HYPERNATRAEMIA 20 0.0040
582 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 220 0.0040
583 DERMATITIS BULLOUS 29 0.0040
584 GENERALISED TONIC-CLONIC SEIZURE 66 0.0040
585 RALES 23 0.0040
586 TOXIC EPIDERMAL NECROLYSIS 60 0.0039
587 LIVER FUNCTION TEST INCREASED 84 0.0039
588 RESPIRATORY DISTRESS 106 0.0038
589 LIVER DISORDER 170 0.0038
590 PERITONITIS 79 0.0038
591 ECCHYMOSIS 26 0.0038
592 CORONARY ARTERY STENOSIS 19 0.0038
593 URINARY RETENTION 126 0.0038
594 STREPTOCOCCAL INFECTION 21 0.0038
595 NAIL DISORDER 33 0.0038
596 GASTROENTERITIS 55 0.0038
597 GASTRITIS 98 0.0037
598 ATRIAL FIBRILLATION 359 0.0037
599 DECUBITUS ULCER 30 0.0037
600 ORTHOSTATIC HYPOTENSION 64 0.0037
601 HYDROCEPHALUS 20 0.0037
602 TACHYCARDIA 325 0.0037
603 LOWER GASTROINTESTINAL HAEMORRHAGE 27 0.0036
604 GANGRENE 22 0.0036
605 HEPATIC STEATOSIS 68 0.0036
606 PNEUMONIA ASPIRATION 91 0.0036
607 COAGULOPATHY 60 0.0036
608 HYPERTRIGLYCERIDAEMIA 21 0.0036
609 ANAPHYLACTIC REACTION 198 0.0036
610 PULMONARY HAEMORRHAGE 28 0.0036
611 CONSTIPATION 778 0.0036
612 SHOCK HAEMORRHAGIC 29 0.0036
613 SKIN ULCER 92 0.0036
614 STAPHYLOCOCCAL INFECTION 117 0.0035
615 URINE OUTPUT DECREASED 31 0.0035
616 HAEMODYNAMIC INSTABILITY 27 0.0035
617 RESPIRATORY TRACT INFECTION 91 0.0035
618 TYPE 1 DIABETES MELLITUS 21 0.0035
619 ANURIA 30 0.0035
620 VISUAL FIELD DEFECT 25 0.0035
621 SKIN REACTION 48 0.0034
622 TRICUSPID VALVE INCOMPETENCE 27 0.0034
623 GASTRIC HAEMORRHAGE 39 0.0034
624 SKIN DISORDER 113 0.0034
625 REFUSAL OF TREATMENT BY PATIENT 22 0.0034
626 MUSCULOSKELETAL CHEST PAIN 52 0.0034
627 MYOPATHY 29 0.0034
628 DIARRHOEA 2167 0.0034
629 NAUSEA 2657 0.0034
630 HAEMORRHAGE INTRACRANIAL 50 0.0033
631 ORAL DISORDER 24 0.0033
632 MITRAL VALVE INCOMPETENCE 37 0.0033
633 SKIN HYPERPIGMENTATION 28 0.0033
634 HEPATOMEGALY 32 0.0033
635 VENTRICULAR FIBRILLATION 36 0.0032
636 MASS 45 0.0032
637 CIRCULATORY COLLAPSE 54 0.0032
638 AUTOIMMUNE HEPATITIS 22 0.0032
639 HYPOTENSION 634 0.0032
640 MOTOR DYSFUNCTION 32 0.0031
641 THROMBOSIS 250 0.0031
642 GENERAL PHYSICAL CONDITION ABNORMAL 21 0.0031
643 TACHYPNOEA 42 0.0031
644 MOUTH ULCERATION 65 0.0031
645 PRODUCT PRESCRIBING ISSUE 67 0.0031
646 HIP ARTHROPLASTY 47 0.0031
647 TASTE DISORDER 62 0.0031
648 ILL-DEFINED DISORDER 185 0.0030
649 INFUSION RELATED REACTION 201 0.0030
650 URINARY TRACT INFECTION 516 0.0030
651 MULTI-ORGAN FAILURE 52 0.0030
652 MOUTH HAEMORRHAGE 22 0.0030
653 APPENDICITIS 28 0.0030
654 DIARRHOEA HAEMORRHAGIC 28 0.0030
655 MENINGITIS 20 0.0030
656 ABSCESS 47 0.0029
657 CARDIOGENIC SHOCK 42 0.0029
658 NERVOUS SYSTEM DISORDER 91 0.0029
659 INTERNATIONAL NORMALISED RATIO INCREASED 83 0.0029
660 DYSPNOEA 1635 0.0029
661 STEVENS-JOHNSON SYNDROME 64 0.0029
662 HYPERTENSION 606 0.0029
663 HAEMODIALYSIS 24 0.0029
664 GLOMERULAR FILTRATION RATE DECREASED 35 0.0028
665 SUBARACHNOID HAEMORRHAGE 29 0.0028
666 BLOOD CALCIUM DECREASED 32 0.0028
667 WOUND INFECTION 31 0.0028
668 SYNCOPE 283 0.0028
669 ALTERED STATE OF CONSCIOUSNESS 61 0.0028
670 OXYGEN SATURATION DECREASED 158 0.0028
671 BRONCHOSPASM 40 0.0028
672 PULMONARY HYPERTENSION 58 0.0028
673 TRANSFUSION 29 0.0028
674 FATIGUE 2151 0.0028
675 BONE DISORDER 50 0.0027
676 CARDIAC ARREST 226 0.0027
677 PULMONARY CONGESTION 36 0.0027
678 ABDOMINAL PAIN LOWER 69 0.0027
679 HEMIPARESIS 46 0.0027
680 DELIRIUM 94 0.0027
681 BLOOD COUNT ABNORMAL 41 0.0027
682 SINUS BRADYCARDIA 26 0.0027
683 PERITONITIS BACTERIAL 27 0.0027
684 DYSURIA 97 0.0026
685 INTENTIONAL PRODUCT USE ISSUE 230 0.0026
686 NO THERAPEUTIC RESPONSE 32 0.0026
687 NODULE 34 0.0026
688 INFUSION SITE PAIN 33 0.0026
689 TOOTH ABSCESS 26 0.0026
690 HIATUS HERNIA 33 0.0025
691 OPTIC NEURITIS 23 0.0025
692 RECTAL HAEMORRHAGE 108 0.0025
693 SPINAL OSTEOARTHRITIS 22 0.0025
694 INFLAMMATION 129 0.0025
695 GRAND MAL CONVULSION 23 0.0025
696 PELVIC PAIN 45 0.0025
697 ASPIRATION 27 0.0025
698 BLOOD PRESSURE SYSTOLIC INCREASED 48 0.0025
699 GASTROINTESTINAL INFECTION 22 0.0025
700 EOSINOPHILIA 43 0.0025
701 DEAFNESS 64 0.0024
702 CEREBRAL HAEMORRHAGE 87 0.0024
703 GASTROINTESTINAL INFLAMMATION 19 0.0024
704 ELECTROCARDIOGRAM ABNORMAL 19 0.0024
705 NIGHT SWEATS 78 0.0024
706 HYPOKINESIA 35 0.0024
707 FLUID OVERLOAD 35 0.0024
708 RETINAL DETACHMENT 22 0.0024
709 ULCER 38 0.0024
710 NEURALGIA 58 0.0024
711 FACE OEDEMA 40 0.0024
712 SKIN PLAQUE 20 0.0024
713 RESPIRATORY RATE INCREASED 21 0.0024
714 ERYTHEMA MULTIFORME 22 0.0024
715 RHABDOMYOLYSIS 98 0.0023
716 ERYTHEMA 483 0.0023
717 DEATH 2024 0.0023
718 MUSCULAR WEAKNESS 265 0.0023
719 LETHARGY 134 0.0023
720 OSTEOMYELITIS 42 0.0023
721 METABOLIC ACIDOSIS 74 0.0023
722 HYPERAESTHESIA 19 0.0023
723 TRANSIENT ISCHAEMIC ATTACK 78 0.0023
724 GASTROINTESTINAL DISORDER 207 0.0023
725 CONFUSIONAL STATE 371 0.0023
726 WEIGHT FLUCTUATION 24 0.0023
727 EMPHYSEMA 23 0.0023
728 BONE PAIN 133 0.0023
729 DYSARTHRIA 85 0.0023
730 HOSPICE CARE 22 0.0022
731 THERAPEUTIC RESPONSE DECREASED 135 0.0022
732 FISTULA 25 0.0022
733 RASH 966 0.0022
734 DYSGEUSIA 164 0.0022
735 HYPOTONIA 22 0.0022
736 IMPAIRED GASTRIC EMPTYING 30 0.0022
737 END STAGE RENAL DISEASE 40 0.0022
738 ALOPECIA 429 0.0022
739 FUNGAL INFECTION 72 0.0022
740 BREAST PAIN 23 0.0022
741 CONJUNCTIVITIS 40 0.0022
742 CARDIO-RESPIRATORY ARREST 90 0.0022
743 DRUG INEFFECTIVE 2831 0.0021
744 PALLOR 58 0.0021
745 UNRESPONSIVE TO STIMULI 55 0.0021
746 GINGIVAL BLEEDING 29 0.0021
747 VENTRICULAR TACHYCARDIA 35 0.0021
748 LEUKAEMIA 20 0.0021
749 CHEST PAIN 390 0.0021
750 UPPER RESPIRATORY TRACT INFECTION 97 0.0021
751 ORAL PAIN 47 0.0021
752 PHARYNGITIS 26 0.0021
753 COUGH 586 0.0021
754 QUALITY OF LIFE DECREASED 28 0.0021
755 WEIGHT DECREASED 582 0.0021
756 PARAESTHESIA 325 0.0021
757 DRUG EFFECT INCOMPLETE 75 0.0021
758 POST PROCEDURAL COMPLICATION 39 0.0020
759 BLADDER DISORDER 20 0.0020
760 DERMATITIS ALLERGIC 25 0.0020
761 DYSPHAGIA 187 0.0020
762 SKIN LESION 54 0.0020
763 HAEMATOMA 51 0.0020
764 HEPATIC ENZYME INCREASED 134 0.0020
765 ATAXIA 23 0.0019
766 FULL BLOOD COUNT DECREASED 39 0.0019
767 BODY TEMPERATURE DECREASED 19 0.0019
768 DRUG INTERACTION 304 0.0019
769 PERICARDITIS 32 0.0019
770 CONDITION AGGRAVATED 579 0.0019
771 DIALYSIS 27 0.0019
772 EYELID OEDEMA 22 0.0019
773 PARALYSIS 27 0.0019
774 PRODUCTIVE COUGH 90 0.0019
775 HYPOTHERMIA 19 0.0019
776 APHASIA 56 0.0019
777 ANGINA PECTORIS 53 0.0018
778 CARDIAC FAILURE CONGESTIVE 147 0.0018
779 RASH ERYTHEMATOUS 87 0.0018
780 DIVERTICULITIS 50 0.0018
781 COVID-19 316 0.0018
782 HERPES ZOSTER 102 0.0018
783 RESPIRATORY DISORDER 53 0.0018
784 NEOPLASM MALIGNANT 118 0.0018
785 OSTEONECROSIS 58 0.0018
786 HAEMORRHAGE 184 0.0018
787 MICTURITION URGENCY 20 0.0017
788 ORAL HERPES 34 0.0017
789 TINNITUS 80 0.0017
790 CHROMATURIA 39 0.0017
791 HAEMATOCHEZIA 95 0.0017
792 HYPERSENSITIVITY 319 0.0017
793 DEPRESSED LEVEL OF CONSCIOUSNESS 67 0.0017
794 ABDOMINAL DISTENSION 176 0.0017
795 EPILEPSY 50 0.0016
796 BLOOD POTASSIUM DECREASED 49 0.0016
797 BREAST CANCER 151 0.0016
798 DISORIENTATION 64 0.0016
799 HYPOGLYCAEMIA 78 0.0016
800 TOOTH INFECTION 21 0.0016
801 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 83 0.0016
802 CEREBROVASCULAR ACCIDENT 269 0.0016
803 PULMONARY ARTERIAL HYPERTENSION 23 0.0016
804 RASH PRURITIC 86 0.0016
805 COMPLICATION ASSOCIATED WITH DEVICE 23 0.0016
806 PANCREATITIS 83 0.0016
807 CYSTITIS 50 0.0016
808 THROAT TIGHTNESS 42 0.0016
809 RENAL INJURY 46 0.0015
810 HEPATIC CIRRHOSIS 29 0.0015
811 IMMUNODEFICIENCY 23 0.0015
812 PRODUCT USE ISSUE 288 0.0015
813 ADVERSE EVENT 141 0.0015
814 CENTRAL NERVOUS SYSTEM LESION 21 0.0015
815 VERTIGO 93 0.0015
816 BACK PAIN 354 0.0015
817 ARRHYTHMIA 72 0.0015
818 HYPOAESTHESIA 226 0.0015
819 VISUAL ACUITY REDUCED 50 0.0015
820 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 44 0.0015
821 PSYCHOTIC DISORDER 44 0.0015
822 LACTIC ACIDOSIS 48 0.0015
823 RENAL DISORDER 69 0.0015
824 SENSORY DISTURBANCE 23 0.0014
825 LOWER RESPIRATORY TRACT INFECTION 65 0.0014
826 BLOOD POTASSIUM INCREASED 23 0.0014
827 SUBDURAL HAEMATOMA 20 0.0014
828 DIPLOPIA 36 0.0014
829 HAEMORRHOIDS 27 0.0014
830 DIABETIC KETOACIDOSIS 33 0.0014
831 IMPAIRED HEALING 45 0.0014
832 BLINDNESS 55 0.0013
833 LUNG NEOPLASM MALIGNANT 55 0.0013
834 CHEST DISCOMFORT 137 0.0013
835 MUSCULOSKELETAL PAIN 70 0.0013
836 RETCHING 28 0.0013
837 PRURITUS 503 0.0013
838 ABDOMINAL PAIN UPPER 267 0.0013
839 BLOOD PRESSURE DECREASED 86 0.0013
840 BLOOD CREATINE PHOSPHOKINASE INCREASED 37 0.0013
841 DYSPHONIA 75 0.0013
842 MYALGIA 217 0.0013
843 HYPERHIDROSIS 164 0.0013
844 LOCAL SWELLING 22 0.0013
845 CHOLELITHIASIS 41 0.0012
846 RASH PAPULAR 28 0.0012
847 POLLAKIURIA 52 0.0012
848 FAECES DISCOLOURED 27 0.0012
849 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 32 0.0012
850 LOSS OF CONSCIOUSNESS 159 0.0012
851 EATING DISORDER 26 0.0012
852 BRADYCARDIA 64 0.0012
853 MALAISE 526 0.0012
854 COMA 57 0.0012
855 PRODUCT ADMINISTRATION ERROR 24 0.0012
856 BLISTER 66 0.0012
857 PHOTOPHOBIA 22 0.0012
858 SCAR 20 0.0012
859 DIABETES MELLITUS 88 0.0012
860 NECK PAIN 64 0.0011
861 ELECTROCARDIOGRAM QT PROLONGED 41 0.0011
862 PAIN 699 0.0011
863 PAIN IN EXTREMITY 335 0.0011
864 CONVULSION 65 0.0011
865 SKIN EXFOLIATION 95 0.0011
866 FLUSHING 114 0.0011
867 DIZZINESS 559 0.0011
868 FEELING HOT 67 0.0011
869 FLUID RETENTION 55 0.0011
870 EAR PAIN 21 0.0011
871 GASTRIC CANCER 27 0.0011
872 CORONARY ARTERY DISEASE 32 0.0011
873 FRACTURE 20 0.0011
874 MUSCULOSKELETAL DISORDER 20 0.0010
875 SPINAL FRACTURE 21 0.0010
876 URINARY INCONTINENCE 31 0.0010
877 GASTROOESOPHAGEAL REFLUX DISEASE 84 0.0010
878 RESTLESSNESS 38 0.0010
879 DYSPEPSIA 101 0.0010
880 CARDIOVASCULAR DISORDER 26 0.0010
881 VAGINAL HAEMORRHAGE 44 0.0010
882 DISCOMFORT 61 0.0010
883 PAIN IN JAW 28 0.0010
884 FEEDING DISORDER 20 0.0010
885 POOR QUALITY SLEEP 21 0.0010
886 MYOCARDIAL INFARCTION 170 0.0010
887 CHRONIC KIDNEY DISEASE 74 0.0010
888 SEIZURE 111 0.0010
889 THERAPEUTIC PRODUCT EFFECT DECREASED 43 0.0010
890 BLOOD PRESSURE INCREASED 143 0.0009
891 WOUND 26 0.0009
892 ARTHROPATHY 51 0.0009
893 FALL 305 0.0009
894 HYPOACUSIS 39 0.0009
895 OSTEOPOROSIS 37 0.0009
896 VISUAL IMPAIRMENT 111 0.0009
897 BRONCHITIS 66 0.0009
898 HEAD INJURY 27 0.0009
899 VISION BLURRED 117 0.0009
900 SWELLING 78 0.0008
901 GAIT DISTURBANCE 159 0.0008
902 PERIPHERAL SWELLING 127 0.0008
903 OROPHARYNGEAL PAIN 76 0.0008
904 AGITATION 60 0.0008
905 HIP FRACTURE 26 0.0008
906 DEPRESSED MOOD 42 0.0008
907 CONTRAINDICATED PRODUCT ADMINISTERED 24 0.0008
908 TREMOR 130 0.0008
909 BALANCE DISORDER 67 0.0008
910 HEART RATE INCREASED 76 0.0008
911 ACCIDENTAL OVERDOSE 28 0.0008
912 ECZEMA 40 0.0008
913 INFLUENZA 85 0.0008
914 SKIN DISCOLOURATION 35 0.0008
915 FLATULENCE 43 0.0008
916 GASTRIC DISORDER 26 0.0008
917 SINUSITIS 77 0.0008
918 LIMB DISCOMFORT 23 0.0007
919 SOMNOLENCE 149 0.0007
920 RESPIRATORY ARREST 20 0.0007
921 NEPHROLITHIASIS 33 0.0007
922 OCULAR HYPERAEMIA 34 0.0007
923 TREATMENT NONCOMPLIANCE 39 0.0007
924 HEADACHE 443 0.0007
925 VIRAL INFECTION 23 0.0007
926 DEPRESSION 156 0.0007
927 DYSSTASIA 20 0.0007
928 CARDIAC DISORDER 64 0.0007
929 OSTEOARTHRITIS 29 0.0007
930 ARTHRALGIA 280 0.0007
931 COGNITIVE DISORDER 31 0.0007
932 BLADDER CANCER 39 0.0007
933 DRY EYE 33 0.0007
934 PALPITATIONS 77 0.0007
935 ANGIOEDEMA 29 0.0007
936 CATARACT 39 0.0007
937 URTICARIA 109 0.0006
938 FEMUR FRACTURE 20 0.0006
939 RASH MACULAR 22 0.0006
940 DRY MOUTH 51 0.0006
941 WEIGHT INCREASED 140 0.0006
942 MOVEMENT DISORDER 20 0.0006
943 SYSTEMIC LUPUS ERYTHEMATOSUS 22 0.0006
944 MOBILITY DECREASED 44 0.0006
945 INFLUENZA LIKE ILLNESS 50 0.0006
946 RHINORRHOEA 39 0.0006
947 INSOMNIA 159 0.0006
948 SPEECH DISORDER 31 0.0006
949 ADVERSE DRUG REACTION 53 0.0006
950 DRY SKIN 78 0.0006
951 SWELLING FACE 38 0.0006
952 COLITIS ULCERATIVE 26 0.0006
953 BLOOD GLUCOSE INCREASED 109 0.0006
954 MEDICATION ERROR 31 0.0006
955 WHEEZING 32 0.0005
956 ARTHRITIS 41 0.0005
957 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 92 0.0005
958 HALLUCINATION 38 0.0005
959 HOT FLUSH 38 0.0005
960 ABDOMINAL DISCOMFORT 83 0.0005
961 NO ADVERSE EVENT 86 0.0005
962 ANXIETY 131 0.0005
963 THERAPY CESSATION 23 0.0004
964 AMNESIA 29 0.0004
965 EXPOSURE DURING PREGNANCY 27 0.0004
966 CONTUSION 41 0.0004
967 BLOOD CHOLESTEROL INCREASED 19 0.0004
968 THERAPY INTERRUPTED 29 0.0004
969 UNDERDOSE 29 0.0004
970 UNEVALUABLE EVENT 30 0.0004
971 SUICIDE ATTEMPT 23 0.0004
972 HOSPITALISATION 54 0.0004
973 MUSCLE SPASMS 62 0.0003
974 EYE PAIN 19 0.0003
975 MATERNAL EXPOSURE DURING PREGNANCY 30 0.0003
976 NASOPHARYNGITIS 59 0.0003
977 INJURY 22 0.0003
978 MUSCULOSKELETAL STIFFNESS 25 0.0003
979 BURNING SENSATION 20 0.0003
980 PROSTATE CANCER 21 0.0003
981 FEELING ABNORMAL 62 0.0003
982 MIGRAINE 24 0.0003
983 OVERDOSE 49 0.0002
984 JOINT SWELLING 26 0.0002
985 MEMORY IMPAIRMENT 28 0.0002
986 INCORRECT DOSE ADMINISTERED 44 0.0002
987 ILLNESS 19 0.0002
988 EMOTIONAL DISTRESS 20 0.0002
989 PRODUCT QUALITY ISSUE 20 0.0001
990 INJECTION SITE PAIN 28 0.0001
991 PRODUCT DOSE OMISSION ISSUE 20 0.0001